Effect of sorafenib on cisplatin-based radiochemotherapy in head and neck cancer cells

被引：0
|
作者：
Moeckelmann, N. [1 ]
Kriegs, M. [2 ]
Rothkamm, K. [2 ]
Dikomey, E. [2 ]
Knecht, R. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Lab Strahlenbiol & Expt Radioonkol, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0214
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [21] Expression of magnesium transporter genes in head and neck cancer patients underwent neoadjuvant cisplatin-based chemotherapy
    Yu-Jung Lin
    Fu-Chou Cheng
    Li-Sheng Chien
    Jin-Ching Lin
    Rong-San Jiang
    Shih-An Liu
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 3051 - 3057
  • [22] Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
    Wolff, Hendrik Andreas
    Overbeck, Tobias
    Roedel, Ralph M.
    Hermann, Robert M.
    Herrmann, Markus K. A.
    Kertesz, Tereza
    Vorwerk, Hilke
    Hille, Andrea
    Matthias, Christoph
    Hess, Clemens F.
    Christiansen, Hans
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (07) : 961 - 967
  • [23] RADIOCHEMOTHERAPY WITH CETUXIMAB, CISPLATIN, AND AMIFOSTINE FOR LOCALLY ADVANCED HEAD AND NECK CANCER: A FEASIBILITY STUDY
    Koukourakis, Michael I.
    Tsoutsou, Pelagia G.
    Karpouzis, Antonios
    Tsiarkatsi, Maria
    Karapantzos, Ilias
    Daniilidis, Vassilios
    Kouskoukis, Constantinos
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 9 - 15
  • [24] Carboplatin/paclitaxel-based radiochemotherapy versus cisplatin-based regimens in locally advanced squamous cell carcinoma of head and neck: analysis of outcome and toxicity
    Maring, S.
    Elsayad, K.
    Stenner, M.
    Rudack, C.
    Haverkamp, U.
    Rehkaemper, J.
    Wardelmann, E.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S74 - S75
  • [25] Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
    Hendrik Andreas Wolff
    Tobias Overbeck
    Ralph M. Roedel
    Robert M. Hermann
    Markus K. A. Herrmann
    Tereza Kertesz
    Hilke Vorwerk
    Andrea Hille
    Christoph Matthias
    Clemens F. Hess
    Hans Christiansen
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 961 - 967
  • [26] Long-term results of postoperative radiochemotherapy with weekly cisplatin in head and neck cancer
    Duque Santana, V.
    Hervas Moron, A.
    Dominguez Rullan, J.
    Vallejo Ocana, C.
    Martin Martin, M.
    Valero Perena, M.
    Moris Pablos, R.
    Sevillano Martinez, D.
    Sancho Garcia, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S930 - S931
  • [27] Postoperative Radiochemotherapy in Patients With Head and Neck Tumours With Weekly Cisplatin
    Hervas, A.
    Vallejo, M. C.
    Morera, R.
    Martinez, J.
    Marcos, S.
    Royuela, A.
    Ramos, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S554 - S555
  • [28] Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition
    Roh, Jong-Lyel
    Kim, Eun Hye
    Jang, Hyejin
    Shin, Daiha
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 104 : 1 - 9
  • [29] Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients
    Das, Nidhin
    Kaushal, Darwin
    Patro, Sourabha Kumar
    Pareek, Puneet
    Dixit, Abhinav
    Soni, Kapil
    Prakasan Nair, Nithin
    Choudhury, Bikram
    Goyal, Amit
    ACTA OTO-LARYNGOLOGICA, 2021, 141 (09) : 885 - 893
  • [30] Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study
    Merlano, M.
    Russi, E.
    Benasso, M.
    Corvo, R.
    Colantonio, I.
    Vigna-Taglianti, R.
    Vigo, V.
    Bacigalupo, A.
    Numico, G.
    Crosetto, N.
    Gasco, M.
    Lo Nigro, C.
    Vitiello, R.
    Violante, S.
    Garrone, O.
    ANNALS OF ONCOLOGY, 2011, 22 (03) : 712 - 717
12345